Angiodynamics (ANGO) Gross Profit (2016 - 2025)
Historic Gross Profit for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $44.8 million.
- Angiodynamics' Gross Profit rose 1222.12% to $44.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $167.7 million, marking a year-over-year increase of 1106.51%. This contributed to the annual value of $157.7 million for FY2025, which is 194.38% up from last year.
- Angiodynamics' Gross Profit amounted to $44.8 million in Q4 2025, which was up 1222.12% from $41.9 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Gross Profit ranged from a high of $46.5 million in Q2 2022 and a low of $35.9 million during Q1 2024
- For the 5-year period, Angiodynamics' Gross Profit averaged around $41.0 million, with its median value being $40.4 million (2023).
- Per our database at Business Quant, Angiodynamics' Gross Profit soared by 4007.68% in 2021 and then crashed by 1692.01% in 2024.
- Angiodynamics' Gross Profit (Quarter) stood at $40.6 million in 2021, then increased by 11.15% to $45.1 million in 2022, then decreased by 10.68% to $40.3 million in 2023, then decreased by 0.88% to $39.9 million in 2024, then increased by 12.22% to $44.8 million in 2025.
- Its Gross Profit was $44.8 million in Q4 2025, compared to $41.9 million in Q3 2025 and $42.2 million in Q2 2025.